Levetiracetam treatment of idiopathic generalised epilepsy
- 31 December 2003
- Vol. 12 (8) , 617-620
- https://doi.org/10.1016/s1059-1311(03)00139-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The anti‐epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA‐ and glycine‐gated currentsBritish Journal of Pharmacology, 2002
- Idiopathic Generalized Epilepsy with Generalized and Other Seizures in AdolescenceEpilepsia, 2001
- Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial SeizuresEpilepsia, 2000
- Levetiracetam for partial seizuresNeurology, 2000
- A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsySeizure, 2000
- Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsyPublished by Elsevier ,1998
- Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetamEpilepsy Research, 1996
- Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsyEpilepsy Research, 1995
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989
- Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic SeizuresEpilepsia, 1981